Stryker Corporation (SYK) : Jensen Investment Management Inc reduced its stake in Stryker Corporation by 1.03% during the most recent quarter end. The investment management company now holds a total of 1,728,620 shares of Stryker Corporation which is valued at $198,497,435 after selling 17,970 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Stryker Corporation makes up approximately 3.00% of Jensen Investment Management Inc’s portfolio.
Other Hedge Funds, Including , Retirement Systems Of Alabama boosted its stake in SYK in the latest quarter, The investment management firm added 745 additional shares and now holds a total of 160,154 shares of Stryker Corporation which is valued at $18,390,484. Stryker Corporation makes up approx 0.10% of Retirement Systems Of Alabama’s portfolio.Norris Perne French Llpmi reduced its stake in SYK by selling 5,097 shares or 4.3% in the most recent quarter. The Hedge Fund company now holds 113,526 shares of SYK which is valued at $13,036,191. Stryker Corporation makes up approx 2.73% of Norris Perne French Llpmi’s portfolio. Leavell Investment Management added SYK to its portfolio by purchasing 2,088 company shares during the most recent quarter which is valued at $255,488. Stryker Corporation makes up approx 0.04% of Leavell Investment Management’s portfolio.Loring Wolcott Coolidge Fiduciary Advisors Llpma reduced its stake in SYK by selling 4,314 shares or 0.32% in the most recent quarter. The Hedge Fund company now holds 1,347,706 shares of SYK which is valued at $165,107,462. Stryker Corporation makes up approx 3.70% of Loring Wolcott Coolidge Fiduciary Advisors Llpma’s portfolio.
Stryker Corporation opened for trading at $114.97 and hit $116.62 on the upside on Friday, eventually ending the session at $116.28, with a gain of 1.15% or 1.32 points. The heightened volatility saw the trading volume jump to 14,53,717 shares. Company has a market cap of $43,524 M.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.